Organon & Co | OGN - Stock


Organon & Co reported $1.37B in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
Bristol-Myers Squibb USD 2.74B 19M Jun/2026
Celltrion KRW 126B 3.06B Mar/2026
Cspc Pharmaceutical CNY 3.09B 219.95M Dec/2025
Divis Laboratories Ltd INR 39.54B 7.18B Mar/2026
Gilead Sciences USD 1.91B 140M Mar/2026
Glaxosmithkline GBP 6.16B 39M Mar/2026
Kangmei Pharma CNY 2.38B 73.9M Mar/2026
Knight Therapeutics CAD 95.4M 2.91M Mar/2024
Laboratorios Farma EUR 327.67M 2.28M Jun/2025
Medical Developments International AUD 9.45M 679K Jun/2025
Merck USD 6.48B 179M Mar/2026
Novartis USD 6.29B 135M Mar/2026
Organigram Holdings CAD 135.16M 2.45M Mar/2026
Organon & Co USD 1.37B 33M Mar/2026
Pharma Mar EUR 49.53M 3.59M Jun/2026
Qiagen NV USD 309.61M 7.72M Mar/2026
Sartorius EUR 831.9M 4.8M Jun/2026
Sino Biopharmaceutical CNY 1.84B 156.17M Jun/2024
Tilray USD 282.79M 11.9M Jun/2025
Zealand Pharma A/S 10.7M 9.9M Dec/2024